Skip to main content
. 2020 Feb 21;21(4):1475. doi: 10.3390/ijms21041475
CTC Circulating tumor cells
RCC Renal cell carcinoma
CNA Copy number analysis
PFS Progression-free survival
OS Overall survival
CN Cytoreductive nephrectomy
TKI Tyrosin kinase inhibitor
CBBs Circulating blood biomarkers
BL BaseLine
DT During treatment